Orbis Medicines Launches with €26 Million Seed Financing to Transform Macrocycle Drug Development through Next-Generation Orally Dosable 'nCycles' | Nation/World
COPENHAGEN, Denmark--(BUSINESS WIRE)--Feb 29, 2024--
Source: bdtonline.com
Sevan Habeshian News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sevan Habeshian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sevan Habeshian Today - Breaking & Trending Today
Orbis Medicines Launches with €26M Seed Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Startup Orbis Medicines Launches With €26M for Next-Generation Peptide Drugs
Orbis Medicines is developing macrocyclic peptides that address a wider range of targets and can be taken as oral pills. Novo Holdings and Forbion are backing the startup, which is based on research from the scientific co-founder of peptide drug developer Bicycle Therapeutics.
Source: medcitynews.com